141 related articles for article (PubMed ID: 29562629)
1. Study of Imidazolium Salt Derivatives as PIK3CA Inhibitors Using a Comprehensive in Silico Method.
Wang MY; Liang JW; Li XY; Olounfeh KM; Li SL; Wang S; Wang L; Meng FH
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562629
[TBL] [Abstract][Full Text] [Related]
2. Determination of Structural Requirements of N-Substituted Tetrahydro-β-Carboline Imidazolium Salt Derivatives Using in Silico Approaches for Designing MEK-1 Inhibitors.
Liang J; Wang M; Li X; He X; Cao C; Meng F
Molecules; 2017 Jun; 22(6):. PubMed ID: 28629184
[TBL] [Abstract][Full Text] [Related]
3. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
[TBL] [Abstract][Full Text] [Related]
4. QSAR Study, Molecular Docking and Molecular Dynamic Simulation of Aurora Kinase Inhibitors Derived from Imidazo[4,5-
Tian YY; Tong JB; Liu Y; Tian Y
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675594
[TBL] [Abstract][Full Text] [Related]
5. Molecular modelling of quinoline derivatives as telomerase inhibitors through 3D-QSAR, molecular dynamics simulation, and molecular docking techniques.
Vishwakarma K; Bhatt H
J Mol Model; 2021 Jan; 27(2):30. PubMed ID: 33415518
[TBL] [Abstract][Full Text] [Related]
6. QSAR studies on imidazopyrazine derivatives as Aurora A kinase inhibitors.
Leng Y; Lu T; Yuan HL; Liu HC; Lu S; Zhang WW; Jiang YL; Chen YD
SAR QSAR Environ Res; 2012 Oct; 23(7-8):705-30. PubMed ID: 22971111
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR (CoMFA, CoMSIA), molecular docking and molecular dynamics simulations study of 6-aryl-5-cyano-pyrimidine derivatives to explore the structure requirements of LSD1 inhibitors.
Ding L; Wang ZZ; Sun XD; Yang J; Ma CY; Li W; Liu HM
Bioorg Med Chem Lett; 2017 Aug; 27(15):3521-3528. PubMed ID: 28610981
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling study for the design of novel acetyl-CoA carboxylase inhibitors using 3D QSAR, molecular docking and dynamic simulations.
Vyas VK; Dabasia M; Qureshi G; Patel P; Ghate M
J Biomol Struct Dyn; 2017 Jul; 35(9):2003-2015. PubMed ID: 27335214
[TBL] [Abstract][Full Text] [Related]
9. Theoretical studies on the selectivity mechanisms of PI3Kδ inhibition with marketed idelalisib and its derivatives by 3D-QSAR, molecular docking, and molecular dynamics simulation.
Zhu J; Ke K; Xu L; Jin J
J Mol Model; 2019 Jul; 25(8):242. PubMed ID: 31338599
[TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
Chaube U; Bhatt H
Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
[TBL] [Abstract][Full Text] [Related]
11. An integrated molecular modeling approach for in silico design of new tetracyclic derivatives as ALK inhibitors.
Peddi SR; Sivan SK; Manga V
J Recept Signal Transduct Res; 2016 Oct; 36(5):488-504. PubMed ID: 26758803
[TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR, molecular dynamics simulations and molecular docking studies of benzoxazepine moiety as mTOR inhibitor for the treatment of lung cancer.
Chaube U; Chhatbar D; Bhatt H
Bioorg Med Chem Lett; 2016 Feb; 26(3):864-874. PubMed ID: 26764189
[TBL] [Abstract][Full Text] [Related]
13. Molecular simulation of a series of benzothiazole PI3Kα inhibitors: probing the relationship between structural features, anti-tumor potency and selectivity.
Wang J; Wang F; Xiao Z; Sheng G; Li Y; Wang Y
J Mol Model; 2012 Jul; 18(7):2943-58. PubMed ID: 22139479
[TBL] [Abstract][Full Text] [Related]
14. A computational strategy to understand structure-activity relationship of 1,3-disubstituted imidazole [1,5-α] pyrazine derivatives described as ATP competitive inhibitors of the IGF-1 receptor related to Ewing sarcoma.
Guaitoli V; Alvarez-Ginarte YM; Montero-Cabrera LA; Bencomo-Martínez A; Badel YP; Giorgetti A; Suku E
J Mol Model; 2020 Aug; 26(8):222. PubMed ID: 32748063
[TBL] [Abstract][Full Text] [Related]
15. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design of hERG-neutral antihypertensive oxazalone and imidazolone derivatives.
Aksoydan B; Kantarcioglu I; Erol I; Salmas RE; Durdagi S
J Mol Graph Model; 2018 Jan; 79():103-117. PubMed ID: 29156380
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3beta inhibitors.
Dessalew N; Patel DS; Bharatam PV
J Mol Graph Model; 2007 Mar; 25(6):885-95. PubMed ID: 17018257
[TBL] [Abstract][Full Text] [Related]
18. Structure-based QSAR, molecule design and bioassays of protease-activated receptor 1 inhibitors.
Zhong W; Liu P; Zhang Q; Li D; Lin J
J Biomol Struct Dyn; 2017 Oct; 35(13):2853-2867. PubMed ID: 27809674
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics insights for PI3K-δ inhibition & structure guided identification of novel PI3K-δ inhibitors.
Srivastava S; Singh Choudhary B; Mehta P; Sukanya ; Sharma M; Malik R
J Biomol Struct Dyn; 2019 Jun; 37(9):2404-2414. PubMed ID: 30047836
[TBL] [Abstract][Full Text] [Related]
20. Docking and three-dimensional quantitative structure-activity relationship analyses of imidazole and thiazolidine derivatives as Aurora A kinase inhibitors.
Im C
Arch Pharm Res; 2016 Dec; 39(12):1635-1643. PubMed ID: 27909956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
